Milam Brantley

Milam Brantley Jr., M.D., Ph.D., associate professor of Ophthalmology and Visual Sciences and Molecular Physiology and Biophysics, recently received a $500,000 grant from the Edward N. and Della L. Thome Memorial Foundation Awards Program in Macular Degeneration Research to further his work on age-related macular degeneration (AMD). Read More

Vanderbilt Eye Institute’s Initiative for Personalized Medicine in Ophthalmology looks for biomarkers that determine a person’s risk of developing any of the three leading causes of blindness. Read More

A person’s mitochondrial gene “signature” could predict risk for diabetic retinopathy and guide early intervention strategies. Read More

Personalized medicine — the effort to tailor health care to individual patients’ needs, genetic profiles and circumstances — is a well-established concept at Vanderbilt University Medical Center. Read More

A panel of metabolites – small molecules that are part of metabolic processes – that are unique to macular degeneration will shed light on the disease and aid diagnosis. Read More

Three Vanderbilt University Medical Center faculty members have been awarded grants from the American Health Assistance Foundation to support their research on glaucoma and macular degeneration — the two leading causes of irreversible blindness in the world. Read More